These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15096326)

  • 1. Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH).
    Holzheimer RG
    Eur J Med Res; 2004 Mar; 9(3):150-70. PubMed ID: 15096326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
    Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
    J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW
    Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis strategies for patients with acute venous thromboembolism.
    Tapson VF
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S524-31; discussion S531-4. PubMed ID: 11732663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for long-term prophylaxis of venous thromboembolism.
    Agnelli G; Mancini GB; Biagini D
    Orthopedics; 2000 Jun; 23(6 Suppl):s643-6. PubMed ID: 10875429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to provide practical treatment for ambulatory patients with deep venous thrombosis].
    Achkar A; Samama MM
    J Mal Vasc; 1999 Feb; 24(1):58-65. PubMed ID: 10192039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN; Wille-Jørgensen PA; Hauch O
    Ugeskr Laeger; 1994 Sep; 156(39):5667-72. PubMed ID: 7985248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for deep vein thrombosis in glioma patients.
    Schmidt F; Faul C; Dichgans J; Weller M
    J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.
    Siragusa S; Anastasio R; Porta C; Falaschi F; Pirrelli S; Palmieri P; Gamba G; Granzow K; Malato A; Minardi V; Tatoni P; Bressan MA; Mariani G
    Arch Intern Med; 2004 Dec 13-27; 164(22):2477-82. PubMed ID: 15596639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic prophylaxis in head trauma and multiple-trauma patients.
    Latronico N; Berardino M
    Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.